Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Transparency: The next generation

Hemp CBD needs ingredient testing and validation at every step.jpg
Consumers would rather see “third-party tested” than “we test our own ingredients” on a CBD label.

I challenge the dietary supplement industry to follow the forward-thinking practices of the cannabis industry. Yes, the Wild Wild West of cannabis—which is stricter about testing than the broader dietary supplement industry, especially in California. California’s Bureau of Cannabis Control (BCC) requires independent testing of all cannabis materials brought to market by BCC-certified testing labs following BCC-approved methods. The results go directly to the BCC, which then approves the release of the vetted product for sale to the public.

Because of this oversight, brands in this space are quick to use these regulatory hoops they have gone through as marketing gold. Cannabis brands proudly brag about their labs, share the data, and go further to tell the story about their farms and manufacturing processes. It’s the reverse of the dietary supplements space, where brands have become more forthcoming about their sourcing and manufacturing but are still vague about ingredient and finished product testing.

Supplement companies spend valuable marketing dollars telling their quality story. They also spend money on ingredient and finished product testing to ensure identity and potency, but the only people who know about that are internal quality assurance (QA)/quality control (QC) teams and auditors.

Consumers would love to see the details of supplement testing results and analytical report details. Alkemist Labs is so convinced of this that it has developed a template for a consumer-friendly certificate of analysis (CoA) suitable for disclosing because it explains what was tested and what the tests found in plain language.

The goal is for this to become industry standard practice.

Elan Sudberg is the CEO of Alkemist Labs.

The full version of this article appears in the digital magazine "CBD: The certified business of disruption."

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.